Gsk (GSK) Inventory Average (2009 - 2026)
Gsk (GSK) posted Inventory Average of $7.6 billion for Q4 2025, up 7.49% on a QoQ basis from $7.1 billion in Q4 2024, and up 7.49% year-over-year from $7.1 billion in Q4 2024.
Gsk (GSK) has 9 years of Inventory Average data on file, last reported at $7.6 billion in Q4 2025.
- In Q4 2025, Inventory Average rose 7.49% year-over-year to $7.6 billion; the TTM figure through Dec 2025 stood at $7.6 billion (up 7.49% YoY), while the FY2025 annual figure was $7.6 billion, up 7.49% from the prior year.
- Inventory Average improved to $7.6 billion in Q4 2025, from $7.1 billion in the prior quarter.
- Across five years, Inventory Average topped out at $7.9 billion in Q4 2021 and bottomed at $6.4 billion in Q4 2023.
- A 5-year average of $7.2 billion and a median of $7.1 billion in 2024 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average slipped 11.97% — and 2024, when it increased 9.64%.
- Year by year, Inventory Average stood at $7.9 billion in 2021, then slipped by 11.97% to $6.9 billion in 2022, then declined by 7.03% to $6.4 billion in 2023, then rose by 9.64% to $7.1 billion in 2024, then increased by 7.49% to $7.6 billion in 2025.
- The last three Inventory Average figures came in at $7.6 billion (Q4 2025), $7.1 billion (Q4 2024), and $6.4 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 2.74 Bn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 14.14 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 14.39 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 5.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 6.57 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 6.21 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.84 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 10.66 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.72 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 7.58 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.09 Bn |
| Dec 31, 2025 | 8.07 Bn |
| Sep 30, 2025 | 8.18 Bn |
| Jun 30, 2025 | 7.83 Bn |
| Mar 31, 2025 | 7.42 Bn |
| Dec 31, 2024 | 7.48 Bn |
| Sep 30, 2024 | 7.54 Bn |
| Jun 30, 2024 | 7.31 Bn |
| Mar 31, 2024 | 7.03 Bn |
| Dec 31, 2023 | 6.88 Bn |
| Sep 30, 2023 | 6.92 Bn |
| Jun 30, 2023 | 6.70 Bn |
| Mar 31, 2023 | 6.27 Bn |
| Dec 31, 2022 | 5.76 Bn |
| Sep 30, 2022 | 5.68 Bn |
| Jun 30, 2022 | 3.60 Bn |
| Mar 31, 2022 | 4.56 Bn |
| Dec 31, 2021 | 8.20 Bn |
| Sep 30, 2021 | 8.73 Bn |
| Jun 30, 2021 | 8.71 Bn |
| Mar 31, 2021 | 8.24 Bn |
| Jun 30, 2020 | 7.79 Bn |
| Mar 31, 2020 | 7.64 Bn |
| Dec 31, 2019 | 8.00 Bn |
| Sep 30, 2019 | 8.01 Bn |
| Jun 30, 2019 | 7.53 Bn |
| Mar 31, 2019 | 7.22 Bn |
| Dec 31, 2018 | 7.30 Bn |
| Sep 30, 2018 | 7.82 Bn |
| Jun 30, 2018 | 7.98 Bn |
| Mar 31, 2018 | 7.62 Bn |
| Dec 31, 2017 | 7.39 Bn |
| Sep 30, 2017 | 7.37 Bn |
| Jun 30, 2017 | 7.02 Bn |
| Mar 31, 2017 | 6.53 Bn |
| Dec 31, 2016 | 6.70 Bn |
| Sep 30, 2016 | 7.48 Bn |
| Jun 30, 2016 | 7.63 Bn |
| Mar 31, 2016 | 7.26 Bn |
| Dec 31, 2015 | 7.34 Bn |
| Sep 30, 2015 | 7.43 Bn |
| Jun 30, 2015 | 7.14 Bn |
| Mar 31, 2015 | 6.82 Bn |
| Dec 31, 2014 | 6.92 Bn |
| Sep 30, 2014 | 7.03 Bn |
| Jun 30, 2014 | 6.85 Bn |
| Mar 31, 2014 | 6.54 Bn |
| Dec 31, 2013 | 6.39 Bn |
| Sep 30, 2013 | 6.41 Bn |
| Jun 30, 2013 | 6.44 Bn |
| Mar 31, 2013 | 3.41 Bn |
| Dec 31, 2012 | 3.33 Bn |
| Sep 30, 2012 | 6.32 Bn |
| Jun 30, 2012 | 6.28 Bn |
| Mar 31, 2012 | 3.30 Bn |
| Dec 31, 2011 | 3.41 Bn |
| Sep 30, 2011 | 6.73 Bn |
| Jun 30, 2011 | 6.71 Bn |
| Mar 31, 2011 | 6.26 Bn |
| Dec 31, 2010 | 6.19 Bn |
| Sep 30, 2010 | 6.20 Bn |
| Jun 30, 2010 | 6.28 Bn |
| Mar 31, 2010 | 6.56 Bn |
| Dec 31, 2009 | 6.76 Bn |
| Sep 30, 2009 | 6.47 Bn |
| Jun 30, 2009 | 5.98 Bn |
| Mar 31, 2009 | 6.14 Bn |